<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-cancers-13-00251">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Min</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Suryadevara</surname>
    <given-names>P.K.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Holbrook</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Feau</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>B.M.</given-names>
   </name>
   <name>
    <surname>Lemoff</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Connelly</surname>
    <given-names>M.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents</article-title>
  <source>J. Med. Chem.</source>
  <year>2016</year>
  <volume>59</volume>
  <fpage>559</fpage>
  <lpage>577</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01092</pub-id>
  <pub-id pub-id-type="pmid">26632965</pub-id>
 </element-citation>
</ref>
